KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 133 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,279,297 | +22.9% | 534,214 | -0.4% | 0.33% | +42.7% |
| Q2 2023 | $7,552,920 | +22.1% | 536,429 | -6.7% | 0.23% | +23.4% |
| Q1 2023 | $6,186,354 | -18.1% | 574,940 | +14.0% | 0.19% | -18.6% |
| Q4 2022 | $7,552,811 | +6.5% | 504,193 | -8.7% | 0.23% | -0.4% |
| Q3 2022 | $7,092,000 | +74.3% | 552,350 | +31.5% | 0.23% | +66.9% |
| Q2 2022 | $4,070,000 | -44.8% | 419,995 | -43.4% | 0.14% | -24.0% |
| Q1 2022 | $7,377,000 | +4.5% | 742,158 | +23.8% | 0.18% | +26.2% |
| Q4 2021 | $7,056,000 | +52.7% | 599,522 | +47.7% | 0.14% | +64.8% |
| Q3 2021 | $4,622,000 | – | 405,834 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |